Mitochondria Could Be Target For Therapeutic Strategy For Alzheimer's Disease Patients

A study in Nature Medicine describes the function and interaction of a critical molecule involved in cell death in Alzheimer's disease patients. These new findings reveal that blocking this molecule, called Cyclophilin D, and development of surrounding mitochondrial targets may be viable therapeutic strategies for the prevention and treatment of Alzheimer's disease, according to Shi Du Yan, Ph.D., at Columbia University Medical Center, who led the multi-center research.

Read the whole article on Science Daily

More from Science Daily